Top Markets
Coin of the day
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rang in Aktien #15162
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Aktienkurs
$1.98
Marktkapitalisierung
$368.99M
Veränderung (1 Tag)
0.90%
Veränderung (1 Jahr)
11.38%
Land
AU
Handel Australian Clinical Labs Limited (ACL)

Kategorie

Aktien-Split-Historie für Australian Clinical Labs Limited (ACL)
Die Aktie Australian Clinical Labs Limited (Symbol: ACL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 01, 2026 statt.
Eine ACL-Aktie, die vor dem Sep 01, 2026 gekauft wurde, entspricht heute 0 ACL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US